As per DelveInsight’s assessment, The Powered staplers are surgical anastomosis devices that utilize battery-powered or electrically driven mechanisms to connect tissues or organs by deploying rows of staples during surgical procedures. They are widely used in operations such as colorectal, gastrointestinal, and thoracic surgeries, where tissue sections need to be cut and rejoined.

DelveInsight’s “Anastomosis Device Market Insights, Competitive Landscape, and Market Forecast – 2034” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Anastomosis Device companies actively working in the market.

Explore the future of healthcare innovation with our comprehensive Anastomosis Device Market Forecast. Stay ahead in the industry!

https://www.delveinsight.com/report-store/anastomosis-device-market

Anastomosis Device Overview

An anastomosis device is a medical instrument used to connect two hollow structures in the body, such as blood vessels, intestines, or other tubular organs, during surgical procedures. These devices help surgeons create a secure and precise connection (anastomosis) after a section of an organ has been removed or bypassed, ensuring proper flow of blood or bodily fluids.

Anastomosis devices are commonly used in gastrointestinal, cardiovascular, and colorectal surgeries, as well as in organ transplantation procedures. They are designed to reduce surgical time, improve consistency in suturing or stapling, and minimize complications such as leakage or infection. Modern anastomosis devices often incorporate advanced stapling technologies and minimally invasive surgical techniques, which help improve surgical outcomes and support faster patient recovery.

Anastomosis Device Market Insights

The anastomosis devices market is experiencing growth due to several interconnected factors, including the increasing number of surgical procedures and the rising prevalence of chronic diseases such as cardiovascular disorders, cancer, and gastrointestinal conditions, which often require surgical removal and reconnection of tissues. Furthermore, the expanding adoption of minimally invasive and robotic-assisted surgical techniques is boosting the demand for advanced anastomosis devices that provide greater precision and support faster patient recovery.

DelveInsight Analysis: The global anastomosis devices market size is projected to grow significantly, increasing from USD 4,159.35 million in 2025 to USD 6,922.84 million by 2034, expanding at a CAGR of 5.86% during the forecast period from 2026 to 2034.

To know more about why North America is leading the market growth in the Anastomosis Device market, get a snapshot of the report Anastomosis Device Market Trends

Recent Developments in the Anastomosis Device Market Report

• In April 2025, Intuitive, a global leader in minimally invasive care and a pioneer in robotic-assisted surgery, announced that the U.S. Food & Drug Administration (FDA) had cleared its fully wristed SP SureForm 45 stapler for use with the da Vinci SP surgical system in thoracic, colorectal, and urologic procedures.

• In March 2025, GT Metabolic™ Solutions, Inc., a global leader in magnetic surgery, announced that the U.S. Food and Drug Administration (FDA) had cleared a larger, 50mm MagDI™ System magnet to complement the system’s existing 40mm magnet. This expansion allowed surgeons to perform magnet-assisted duodenal-ileal anastomosis on a broader range of patients.

• In September 2024, GT Metabolic™ Solutions, Inc., a company focused on reinventing bariatric, metabolic, and digestive surgery, announced that its first-generation MagDI™ System for side-to-side duodeno-ileal anastomosis had received De Novo marketing authorization from the U.S. Food and Drug Administration (FDA).In June 2024, Aktiia received regulatory approval for the world’s first optical blood pressure system, CALFREE™, which can be used without the need for calibration with a regular cuff.

• In August 2025, Phraxis, Inc., a leader in vascular access innovation, announced the successful completion of the first commercial case using its EndoForce™ Anastomotic Connector, marking a historic milestone in the treatment of dialysis patients worldwide.

• In May 2024, Ethicon, a Johnson & Johnson MedTech company, announced the U.S. launch of the ECHELON LINEAR™ Cutter. It became the first linear cutter on the market to combine two innovative proprietary technologies 3D-Stapling Technology and Gripping Surface Technology (GST) both designed to enhance staple line security, helping surgeons reduce risks and improve patient outcomes.

Key Players in the Anastomosis Device Market

Some of the key market players operating in the Anastomosis Device market include- B.Braun SE, Intuitive Surgical Operations, Inc., Baxter, Johnson & Johnson and its affiliates, Medtronic, Sinolinks Medical Innovation, Inc., BIOWIN PHARMACEUTICAL CO., LIMITED, DOLPHIN SUTURES, Golden Stapler Surgical Co., Ltd, Changzhou Haiers Medical Devices Co., Ltd, Getinge AB, Terumo Corporation, ConMed Corporation, Teleflex Incorporated, Dextera Surgical Inc., Peters surgical, MIZUHO Corporation, CarpoNovum AB, Purple Surgical, LP, Seger Surgical Solutions Ltd. and others.

To read more about the latest highlights related to Anastomosis Device, get a snapshot of the key highlights entailed in the Anastomosis Device Market Forecast Report

Market Analysis on the Anastomosis Device Market

According to estimates, North America is projected to hold the largest share of the anastomosis devices market in 2025, accounting for approximately 42% of the global market. The region is anticipated to lead the overall market due to its advanced healthcare infrastructure, high volume of surgical procedures, and rapid adoption of innovative surgical technologies. Additionally, the strong presence of major medical device manufacturers, along with ongoing investments in research and product development, supports the introduction and adoption of technologically advanced anastomosis devices in the region.

The competitive landscape of the anastomosis devices market is driven by strong innovation, strategic collaborations, regulatory approvals, and product differentiation as companies aim to deliver safer and more efficient surgical solutions. Leading medical device manufacturers are continuously enhancing their product portfolios with advanced stapling systems, automated technologies, and minimally invasive devices to align with surgeon preferences and minimize surgical complications. Moreover, the market competition is further influenced by emerging technological developments such as magnetic compression anastomosis, bioabsorbable connectors, and intelligent devices with integrated feedback systems, all of which contribute to improved procedural outcomes.

Scope of the Anastomosis Device Market Report

• Coverage: Global

• Study Period: 2023–2034

• Anastomosis Device Market Segmentation By Product Type: Surgical Staplers {Powered, Manual}, Surgical Sutures, Surgical Sealant, Surgical Adhesives, and others

• Anastomosis Device Market Segmentation By Usability: Disposable and Reusable

• Anastomosis Device Market Segmentation By Application: Cardiovascular Surgery, Gastrointestinal Surgery, General Surgery, and others

• Anastomosis Device Market Segmentation By End User: Hospitals & Clinics, Ambulatory Surgical Centers, and others

• Anastomosis Device Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World

• Key Anastomosis Device Companies: B.Braun SE, Intuitive Surgical Operations, Inc., Baxter, Johnson & Johnson and its affiliates, Medtronic, Sinolinks Medical Innovation, Inc., BIOWIN PHARMACEUTICAL CO., LIMITED, DOLPHIN SUTURES, Golden Stapler Surgical Co., Ltd, Changzhou Haiers Medical Devices Co., Ltd, Getinge AB, Terumo Corporation, ConMed Corporation, Teleflex Incorporated, Dextera Surgical Inc., Peters surgical, MIZUHO Corporation, CarpoNovum AB, Purple Surgical, LP, Seger Surgical Solutions Ltd. and others

• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the Anastomosis Device market are set to emerge as the trendsetter explore @ Anastomosis Device Manufacturer

Table of Contents

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/